Business and Builders

Growth Equity

2 articles

Editorial illustration for OrbiMed Raises $3 Billion for Two New Healthcare Funds, Split Between US-Europe Venture and Asia Growth
Funding & Finance

OrbiMed Raises $3 Billion for Two New Healthcare Funds, Split Between US-Europe Venture and Asia Growth

OrbiMed has raised $3 billion across two new private equity funds, with over $1.9 billion dedicated to US and European venture-stage life sciences and over $1 billion targeting Asia's healthcare growth and venture capital.

Sofia Reyes·October 16, 2026
Benchmark Capital's new $2 billion fund announcement, highlighting their expansion into growth-stage investments alongside early-stage funding.
Growth & Strategy

Benchmark Raises $2 Billion for New Growth and Early-Stage Funds

Benchmark Capital, long synonymous with early-stage venture funding, just closed on $2 billion across two new funds.

Sofia Reyes·June 4, 2026